Results for “Radiation Protection” — Page 93

DOE OSTI2016

WE-AB-207B-12: Prospective Study of the Relationship Between Dose-Volume Clinical Toxicity and Patient Reported Outcomes in Lung Cancer Patients Treated with SBRT

Purpose: To determine in a prospective study, the correlation between radiation dose/volume, clinical toxicities and patient-reported, quality of life (QOL) resulting from lung SBRT. Methods: For 106 non-small cell lung cancer (NSCLC) patients receiving SBRT (12 Gy × 4), symptoms including cough, dyspnea, fatigue and pneumonitis were measured at baseline (before treatment), after treatment and 3, 6, and 12 months post-treatment. Toxicity was graded from zero to five. Dosimetric parameters such as the MLD, D10%, D20%, and lung subvolumes (V10 and V20) were obtained from the treatment plan. Dosimetric parameters and number of patients demonstrating toxicity ≥ grade 2 were tabulated. Linear regression analysis was used to calculate correlations between MLD and D10, D20, V10 and V20. Results: The percentages of patients with > grade 2 pneumonitis, fatigue, cough, and dyspnea over 3 to 12 months increased from 0.0% to 3.5%, 3.2% to 10.5%, 4.3% to 8.3%, and 10.8% to 18.8%, respectively. Computed dose indices D10%, D20% were 7.9±4.8 Gy and 3.0±2.3 Gy, respectively. MLD ranged from 0.34 Gy up to 9.9 Gy with overall average 3.0±1.7 Gy. The averages of the subvolumes V10 and V20 were respectively 8.9±5.3% and 3.0±2.4%. The linear regression analysis showed that V10 and D10 demonstrated the strongest correlation to MLD; R2= 0.92 and 0.87, respectively. V20, and D20 were also strongly correlated with MLD; R2 = 0.81 and 0.84 respectively. A correlation was also found to exist between MLD > 2 Gy and ≥ grade 2 cough and dyspnea. Subvolume values for 2Gy MLD were 5.3% for V10 and 2% for V20. Conclusion: Dosimetric indices: MLD ≥ 2Gy, D10 ≥ 5Gy and V10 ≥ 5% of the total lung volume were predictive of > grade 2 cough and dyspnea QOL data. The QOL results are a novel component of this work. acknowledgement of the Varian grant support.

60 APPLIED LIFE SCIENCES↗

DOE OSTI2016

WE-H-207B-00: MRgRT

In recent years, steady progress has been made towards the implementation of MRI in external beam radiation therapy for processes ranging from treatment simulation to in-room guidance. Novel procedures relying mostly on MR data are currently implemented in the clinic. This session will cover topics such as (a) commissioning and quality control of the MR in-room imagers and simulators specific to RT, (b) treatment planning requirements, constraints and challenges when dealing with various MR data, (c) quantification of organ motion with an emphasis on treatment delivery guidance, and (d) MR-driven strategies for adaptive RT workflows. The content of the session was chosen to address both educational and practical key aspects of MR guidance. Learning Objectives: Good understanding of MR testing recommended for in-room MR imaging as well as image data validation for RT chain (e.g. image transfer, filtering for consistency, spatial accuracy, manipulation for task specific); Familiarity with MR-based planning procedures: motivation, core workflow requirements, current status, challenges; Overview of the current methods for the quantification of organ motion; Discussion on approaches for adaptive treatment planning and delivery. T. Stanescu - License agreement with Modus Medical Devices to develop a phantom for the quantification of MR image system-related distortions.; T. Stanescu, N/A.

60 APPLIED LIFE SCIENCES↗

DOE OSTI2016

WE-H-207B-02: MR-Driven RT Planning

In recent years, steady progress has been made towards the implementation of MRI in external beam radiation therapy for processes ranging from treatment simulation to in-room guidance. Novel procedures relying mostly on MR data are currently implemented in the clinic. This session will cover topics such as (a) commissioning and quality control of the MR in-room imagers and simulators specific to RT, (b) treatment planning requirements, constraints and challenges when dealing with various MR data, (c) quantification of organ motion with an emphasis on treatment delivery guidance, and (d) MR-driven strategies for adaptive RT workflows. The content of the session was chosen to address both educational and practical key aspects of MR guidance. Learning Objectives: Good understanding of MR testing recommended for in-room MR imaging as well as image data validation for RT chain (e.g. image transfer, filtering for consistency, spatial accuracy, manipulation for task specific); Familiarity with MR-based planning procedures: motivation, core workflow requirements, current status, challenges; Overview of the current methods for the quantification of organ motion; Discussion on approaches for adaptive treatment planning and delivery. T. Stanescu - License agreement with Modus Medical Devices to develop a phantom for the quantification of MR image system-related distortions.; T. Stanescu, N/A.

60 APPLIED LIFE SCIENCES↗

DOE OSTI2016

WE-H-207B-03: MRI Guidance in the Radiation Therapy Clinic: Site-Specific Discussions

In recent years, steady progress has been made towards the implementation of MRI in external beam radiation therapy for processes ranging from treatment simulation to in-room guidance. Novel procedures relying mostly on MR data are currently implemented in the clinic. This session will cover topics such as (a) commissioning and quality control of the MR in-room imagers and simulators specific to RT, (b) treatment planning requirements, constraints and challenges when dealing with various MR data, (c) quantification of organ motion with an emphasis on treatment delivery guidance, and (d) MR-driven strategies for adaptive RT workflows. The content of the session was chosen to address both educational and practical key aspects of MR guidance. Learning Objectives: Good understanding of MR testing recommended for in-room MR imaging as well as image data validation for RT chain (e.g. image transfer, filtering for consistency, spatial accuracy, manipulation for task specific); Familiarity with MR-based planning procedures: motivation, core workflow requirements, current status, challenges; Overview of the current methods for the quantification of organ motion; Discussion on approaches for adaptive treatment planning and delivery. T. Stanescu - License agreement with Modus Medical Devices to develop a phantom for the quantification of MR image system-related distortions.; T. Stanescu, N/A.

60 APPLIED LIFE SCIENCES↗

DOE OSTI2016

WE-H-207B-04: Strategies for Adaptive RT

In recent years, steady progress has been made towards the implementation of MRI in external beam radiation therapy for processes ranging from treatment simulation to in-room guidance. Novel procedures relying mostly on MR data are currently implemented in the clinic. This session will cover topics such as (a) commissioning and quality control of the MR in-room imagers and simulators specific to RT, (b) treatment planning requirements, constraints and challenges when dealing with various MR data, (c) quantification of organ motion with an emphasis on treatment delivery guidance, and (d) MR-driven strategies for adaptive RT workflows. The content of the session was chosen to address both educational and practical key aspects of MR guidance. Learning Objectives: Good understanding of MR testing recommended for in-room MR imaging as well as image data validation for RT chain (e.g. image transfer, filtering for consistency, spatial accuracy, manipulation for task specific); Familiarity with MR-based planning procedures: motivation, core workflow requirements, current status, challenges; Overview of the current methods for the quantification of organ motion; Discussion on approaches for adaptive treatment planning and delivery. T. Stanescu - License agreement with Modus Medical Devices to develop a phantom for the quantification of MR image system-related distortions.; T. Stanescu, N/A.

60 APPLIED LIFE SCIENCES↗

DOE OSTI2016

TH-AB-207A-09: Tailoring TCM Schemes to a Task: Evaluating the Impact of Customized TCM Profiles On Detection of Lung Nodules in Simulated CT Lung Cancer Screening

Purpose: Recent work has shown that current TCM profile designs boost detection of low-contrast lung lesions in the lung apices, but yield reduced detection performance in the mid and lower lung regions relative to fixed tube current cases. This observed imbalance suggests that the TCM scheme might be tailored in new ways to maximize nodule detection throughout the entire lung. In this work, we begin a preliminary investigation into custom TCM profiles in an attempt to achieve uniform lesion detection throughout the extent of the lung. Methods: Low-contrast (25HU), 6mm nodules representing ground glass opacities were simulated at 1mm intervals over the length the lungs in a voxelized model of the XCAT phantom, one nodule per lung, per simulated scan. Voxel values represented attenuation values at 80keV. CT projection data was created by simulating a finite focal spot and using Joseph’s method for forward projection; scanner geometry was that of the Siemens Sensation 64 and the X-ray source was simulated as an 80keV monochromatic beam. Noise realizations were created using Poisson statistics, a realistic bowtie filter and varying tube current. 500 noise realizations were created for the custom TCM designs. All reconstruction was done with FreeCT-wFBP. An SKE/BKE task was used in conjunction with a 2D Hotelling Observer to calculate area-under-the-curve (AUC) as a proxy for “detectability.” AUC was plotted as a function of nodule Z-location to create a “detectability map.” The detectability map for the custom TCM curve was qualitatively assessed relative to previous results for the fixed TC and clinical TCM cases for uniformity. Results: Detection uniformity was improved throughout the mid and lower lungs, however detection remained disproportionately high in the upper lung region. Conclusion: Detection uniformity was improved with a custom TC profile. Future work will incorporate an analytic, task-specific approach to optimize the TC scheme for nodule detection. J. Hoffman: Part-time intern, Toshiba Medical Research Institute; M. McNitt-Gray: Institutional research agreement, Siemens Healthcare; Past recipient, research grant support, Siemens Healthcare; Consultant, Toshiba America Medical Systems; Consultant, Samsung Electronics; F. Noo: Institutional research agreement, Siemens Healthcare; Receives research funding from Siemens Healthcare.

60 APPLIED LIFE SCIENCES↗

DOE OSTI2016

TH-CD-209-08: Quantification of the Interplay Effect in Proton Pencil Beam Scanning Treatment of Lung

Purpose: To quantify the dose degradation caused by the interplay effect based on a beam specific motion analysis in proton pencil beam scanning (PBS) treatment of lung tumors Methods: PBS plans were optimized on average CT using a beam-specific PTV method for 10 consecutive patients with locally advanced non-small-cell-lung-cancer (NSCLC) treated with proton therapy to 6660/180 cGy. End inhalation (CT0) and end exhalation (CT50) were selected as the two extreme scenarios to acquire the relative stopping power ratio difference (Δrsp) for a respiration cycle. The water equivalent difference (ΔWET) per radiological path was calculated from the surface of patient to the iCTV by integrating the Δrsp of each voxel. The motion magnitude of each voxel within the target follows a quasi-Gaussian distribution. A motion index (MI (>5mm WET)), defined as the percentage of target voxels with an absolute integral ΔWET larger than 5 mm, was adopted as a metric to characterize interplay. To simulate the treatment process, 4D dose was calculated by accumulating the spot dose on the corresponding respiration phase to the reference phase CT50 by deformable image registration based on spot timing and patient breathing phase. Results: The study indicated that the magnitude of target underdose in a single fraction plan is proportional to the MI (p<0.001), with larger motion equating to greater dose degradation and standard deviations. The target homogeneity, minimum, maximum and mean dose in the 4D dose accumulations of 37 fractions varied as a function of MI. Conclusion: The MI quantification metric can predict the level of dose degradation in PBS lung cancer treatment, which potentially serves as a clinical decision tool to assess whether patients are suitable to receive PBS treatment.

60 APPLIED LIFE SCIENCES↗

DOE OSTI2016

Delivered dose uncertainty analysis at the tumor apex for ocular brachytherapy

Purpose: To estimate the total dosimetric uncertainty at the tumor apex for ocular brachytherapy treatments delivered using 16 mm Collaborative Ocular Melanoma Study (COMS) and Super9 plaques loaded with {sup 125}I seeds in order to determine the size of the apex margin that would be required to ensure adequate dosimetric coverage of the tumor. Methods: The total dosimetric uncertainty was assessed for three reference tumor heights: 3, 5, and 10 mm, using the Guide to the expression of Uncertainty in Measurement/National Institute of Standards and Technology approach. Uncertainties pertaining to seed construction, source strength, plaque assembly, treatment planning calculations, tumor height measurement, plaque placement, and plaque tilt for a simple dome-shaped tumor were investigated and quantified to estimate the total dosimetric uncertainty at the tumor apex. Uncertainties in seed construction were determined using EBT3 Gafchromic film measurements around single seeds, plaque assembly uncertainties were determined using high resolution microCT scanning of loaded plaques to measure seed positions in the plaques, and all other uncertainties were determined from the previously published studies and recommended values. All dose calculations were performed using PLAQUESIMULATOR v5.7.6 ophthalmic treatment planning system with the inclusion of plaque heterogeneity corrections. Results: The total dosimetric uncertainties at 3, 5, and 10 mm tumor heights for the 16 mm COMS plaque were 17.3%, 16.1%, and 14.2%, respectively, and for the Super9 plaque were 18.2%, 14.4%, and 13.1%, respectively (all values with coverage factor k = 2). The apex margins at 3, 5, and 10 mm tumor heights required to adequately account for these uncertainties were 1.3, 1.3, and 1.4 mm, respectively, for the 16 mm COMS plaque, and 1.8, 1.4, and 1.2 mm, respectively, for the Super9 plaque. These uncertainties and associated margins are dependent on the dose gradient at the given prescription depth, thus resulting in the changing uncertainties and margins with depth. Conclusions: The margins determined in this work can be used as a guide for determining an appropriate apex margin for a given treatment, which can be chosen based on the tumor height. The required margin may need to be increased for more complex scenarios (mushroom shaped tumors, tumors close to the optic nerve, oblique muscle related tilt, etc.) than the simple dome-shaped tumor examined and should be chosen on a case-by-case basis. The sources of uncertainty contributing most significantly to the total dosimetric uncertainty are seed placement within the plaques, treatment planning calculations, tumor height measurement, and plaque tilt. This work presents an uncertainty-based, rational approach to estimating an appropriate apex margin.

60 APPLIED LIFE SCIENCES↗

DOE OSTI2016

Sci-Thur PM – Brachytherapy 06: 3D Printed Surface Applicators for High Dose Rate Brachytherapy

Purpose: The purpose of this work is to develop a new applicator for administering high dose rate (HDR) brachytherapy using 3D printing technology. Primary advantages of using a 3D printed applicator will be to offer a more streamlined approach for therapists and patients while achieving better conformity, reproducibility, and patient specific applicators. Methods: A phantom study was conducted to measure the effectiveness of a 3D printed surface applicator by analyzing tumours on three locations of the body: the foot, nose, and scalp. The applicator was designed using Eclipse and further modified using Blender to create the catheter tunnels before being printed on a Lulzbot Taz 5 3D printer. A radiation plan was made using Oncentra Brachytherapy for a control treatment option using Freiburg Flaps and one with the novel method of a 3D printed applicator. A comparative analysis was made using D90, D100, V100, V150, and V200 Results: The 3D printed applicator showed comparable dose coverage with significant improvements on highly irregular surfaces when analyzed against a plan made using Freiburg Flaps. Although both plans exhibited complete tumour coverage, the 3D applicator showed improvements in D90 and V150 and the 3D applicator had a dose homogeneity index (DHI) of 0.99 compared to a DHI of 0.97 for the control. Therapist prep time also dropped significantly due to the lack of need for a thermoplastic mesh. Conclusions: 3D printed applicators for treatment of superficial sites proved to offer more patient convenience, less prep time, better conformity and tighter margins.

60 APPLIED LIFE SCIENCES↗

DOE OSTI2022

Health Physics Research Reactor Criticality Accident Alarm System Benchmark Overview

From the countless critical experiments performed in the world during the past century, high-quality integral benchmarks experiments have been collected and gathered into the International Handbook of Evaluated Criticality Safety Benchmark Experiments (ICSBEP Handbook), managed by the International Criticality Safety Benchmark Evaluation Project (ICSBEP) Working Group. This information preservation and dissemination effort is crucial for reactor licensing as well as criticality and radiation transport modeling validation. This summary reports on the status of a tentative benchmark addition to the ICSBEP Handbook. The proposed benchmark arises from legacy operation data of the Oak Ridge National Laboratory (ORNL) Health Physics Research Reactor (HPRR). The HPRR was a small, unmoderated, unshielded fast burst reactor that was used for research in health physics and radiobiology as well as teaching and training. As part of a comprehensive investigation of the available HPRR operation data and characteristics, different possibilities for use of the valuable results were studied. A critical experiment benchmark evaluation was performed, analyzing data coming from sub-critical and critical operation of the HPRR during operator training, steady-state irradiation of samples and before critical bursts. The results of the evaluation do not satisfy for the ICSBEP standards as the benchmark relative standard uncertainty is of about 4% for k eff , and the relative difference between sample calculations and expected k eff results is of about 1.5%. Due to those unsatisfactory results, it was decided not to pursue critical experiments evaluation of the HPRR presently and to focus instead on shielding type data for the creation of a criticality accident alarm system (CAAS) and shielding category benchmark, which is currently very scarce in the ICSBEP handbook—especially concerning critical, pulsed assembly, or reactor operation data. Several dosimetry and shielding experiments from HPRR burst operation were evaluated, with different benchmark metrics as sulfur fluence, Element 57 dose, or neutron fluence at different distances and under different shield materials conditions. An evaluation focusing on the Element 57 neutron dose as a benchmark metric was submitted to the ICSBEP Technical Review Group (TRG) meeting in October 2021, and the inclusion of the evaluation in the ICSBEP Handbook was deferred. The main change proposed by the international experiment evaluation experts is to use the neutron fluence measured by Bonner spheres as a benchmark metric. This represents a quantity closer to that actually measured by the experimentalists of the HPRR compared to the Element 57 dose, which adds another step of data transformation, thus potentially adding uncertainty to the benchmark. The evaluation has been updated and will be submitted to the 2022 ICSBEP TRG meeting for inclusion in the 2023 edition of the ICSBEP Handbook. The evaluation is performed using the KENO and MAVRIC combination from the SCALE 6.2.4 code suite which was previously used in similar CAAS benchmarks to allow for the use of variance reduction techniques.

61 RADIATION PROTECTION AND DOSIMETRY↗

DOE OSTI2015

Enhancements to the MCNP6 background source

The particle transport code MCNP has been used to produce a background radiation data file on a worldwide grid that can easily be sampled as a source in the code. Location-dependent cosmic showers were modeled by Monte Carlo methods to produce the resulting neutron and photon background flux at 2054 locations around Earth. An improved galactic-cosmic-ray feature was used to model the source term as well as data from multiple sources to model the transport environment through atmosphere, soil, and seawater. A new elevation scaling feature was also added to the code to increase the accuracy of the cosmic neutron background for user locations with off-grid elevations. Furthermore, benchmarking has shown the neutron integral flux values to be within experimental error.

61 RADIATION PROTECTION AND DOSIMETRY↗

DOE OSTI2012

Criticality Safety Basics for INL Emergency Responders

This document is a modular self-study guide about criticality safety principles for Idaho National Laboratory emergency responders. This guide provides basic criticality safety information for people who, in response to an emergency, might enter an area that contains much fissionable (or fissile) material. The information should help responders understand unique factors that might be important in responding to a criticality accident or in preventing a criticality accident while responding to a different emergency. This study guide specifically supplements web-based training for firefighters (0INL1226) and includes information for other Idaho National Laboratory first responders. However, the guide audience also includes other first responders such as radiological control personnel. For interested readers, this guide includes clearly marked additional information that will not be included on tests. The additional information includes historical examples (Been there. Done that.), as well as facts and more in-depth information (Did you know …). INL criticality safety personnel revise this guide as needed to reflect program changes, user requests, and better information. Revision 0, issued May 2007, established the basic text. Revision 1 incorporates operation, program, and training changes implemented since 2007. Revision 1 increases focus on first responders because later responders are more likely to have more assistance and guidance from facility personnel and subject matter experts. Revision 1 also completely reorganized the training to better emphasize physical concepts behind the criticality controls that help keep emergency responders safe. The changes are based on and consistent with changes made to course 0INL1226.

61 RADIATION PROTECTION AND DOSIMETRY↗

DOE OSTI2013

Site-Directed Research and Development FY 2012 Annual Report

The reports included in this report are for project activities that occurred from October 2011 through September 2012. These reports describe in detail the discoveries, achievements, and challenges encountered by our talented and enthusiastic principal investigators (PIs). Many of the reports describe R&D efforts that were “successful” in their pursuits and resulted in a positive outcome or technology realization. As we’ve stated before, and continue to stress, in some cases the result is a “negative” finding, for instance a technology is currently impractical or out of reach. This can often be viewed erroneously as a “failure,” but is actually a valid outcome in the pursuit of high-risk research, which often leads to unforeseen new paths of discovery. Either result advances our knowledge and increases our ability to identify solutions and/or likewise avoid costly paths not appropriate for the challenges presented. The SDRD program continues to provide an unfettered mechanism for innovation and development that returns multifold to the NNSS mission. Overall the program is a strong R&D innovation engine, benefited by an enhanced mission, committed resources, and sound competitiveness to yield maximum benefit. The 23 projects described exemplify the creativity and ability of a diverse scientific and engineering talent base. The efforts also showcase an impressive capability and resource that can be brought to find solutions to a broad array of technology needs and applications relevant to the NNSS mission and national security.

36 MATERIALS SCIENCE↗

DOE OSTI2013

On the Alpha Radiation Damage to the O-Ring Seal of the SAVY-4000 Container

In this memo, the dose to an O-ring from the alpha decay of 238 PuO 2 is calculated. These calculations were made in order to assess possible radiation damage to the O-ring, which could lead to failure and loss of integrity of the seal created by the O-ring. The O-ring being discussed here provides the seal between the lid and bottom of a nuclear materials container. The container will be used for the storage and transport of a number of different radioactive materials. The analysis is made using 238 PuO 2 as it would create the greatest damage to the O-ring when considering the materials that may be stored in it. Contamination of the O-ring is not expected to occur. But in the event radioactive material comes in contact with the O-ring, these calculations provide an estimate of the radiation damage.

07 ISOTOPE AND RADIATION SOURCES↗

DOE OSTI2013

Quick-Start Guide to Low-Energy Photon/Electron Transport in MCNP6

A new feature of the particle transport code MCNP6 is the ability to transport photons and electrons below the traditional lower energy limit of 1 keV. Full discussions of this new capability, its supporting data, and its methods, especially the new single-event electron transport, a data-based method that replaces condensed-history in selected energy ranges, will appear in various publications in the near future. In this document, we present a few practical points that users of the new feature will need to know.

61 RADIATION PROTECTION AND DOSIMETRY↗

DOE OSTI2013

MCNP6™ Release 1.0: Creating and Testing the Code Distribution

This report documents the preparations for and testing of the production release of MCNP6™ through RSICC at ORNL. It addresses tests on supported operating systems (Linux, MacOSX, Windows) with the supported compilers (Intel, Portland Group International, PathsScale and gfortran). Verification and Validation test results are documented elsewhere. This report does not address in detail the overall packaging of the distribution. Specifically, it does not address the nuclear and atomic data collection, the other included software packages (MCNP5 and MCNPX) and the collection of reference documents.

07 ISOTOPE AND RADIATION SOURCES↗

DOE OSTI2013

Description of and MCNP Input Files for a Duct-Shielding Benchmark

A brief description of a one-, two-, and three-legged duct shielding benchmark and the MCNP model input files are given. The duct-shielding benchmark measurements were taken by Maerker and Muckenthaler [1967] at the Oak Ridge Tower Shielding Facility. The ducts were constructed from reinforced concrete. The experimental values are found to fall between MCNP simulations with homogenized reinforced concrete and the basic concrete.

61 RADIATION PROTECTION AND DOSIMETRY↗

DOE OSTI2014

LLNL Final Design for PDV Measurements of Godiva for Validation of Multi-Physics Simulation

This document is a Final Design (CED-2) Report for IER-268, “PDV Measurements of Godiva for Validation of Multi-Physics Simulation”. These measurements will measure surface velocities in several locations, the initial α and α-t curve as a function of fission yield using existing LLNL assets including: The portable Photonic Doppler Velocimeter (PDV) detector; The “alpha box”, and; Aluminum-encapsulated 235 U fission foils. These experiments will be simulated using multi-physics methods funded separately under LLNL-AM2. A supercritical benchmark specification will be developed; and, if funding permits, an ICSBEP (or classified equivalent) evaluation will be published.

22 GENERAL STUDIES OF NUCLEAR REACTORS↗